Today the European Medicines Agency will meet to discuss extending the use of Spikevax vaccine (previously known as Moderna), to include children aged 12 to 18. With the spread of the virus is now thriving in young people should we start vaccinating children here? To discuss Vincent spoke to Paul Moynagh Professor of Immunology and Director of the Kathleen Lonsdale Institute for Human Health Research at Maynooth University.
Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.
Download, listen and subscribe on the Newstalk App.
You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.
